,0
zip,91320-1799
sector,Healthcare
fullTimeEmployees,24200
longBusinessSummary,"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."
city,Thousand Oaks
phone,805 447 1000
state,CA
country,United States
companyOfficers,[]
website,https://www.amgen.com
maxAge,1
address1,One Amgen Center Drive
fax,805 447 1010
industry,Drug Manufacturers—General
ebitdaMargins,0.48988998
profitMargins,0.21746999
grossMargins,0.75205004
operatingCashflow,9320999936
revenueGrowth,0.057
operatingMargins,0.36661997
ebitda,12892000256
targetLowPrice,185
recommendationKey,hold
grossProfits,19525000000
freeCashflow,7442625024
targetMedianPrice,250
currentPrice,255.26
earningsGrowth,-0.053
currentRatio,1.437
returnOnAssets,0.09907
numberOfAnalystOpinions,23
targetMeanPrice,249.25
debtToEquity,4023.362
returnOnEquity,1.11668
targetHighPrice,295
totalCash,6544000000
totalDebt,36854001664
totalRevenue,26315999232
totalCashPerShare,12.25
financialCurrency,USD
revenuePerShare,46.763
quickRatio,0.902
recommendationMean,2.6
exchange,NMS
shortName,Amgen Inc.
longName,Amgen Inc.
exchangeTimezoneName,America/New_York
exchangeTimezoneShortName,EDT
isEsgPopulated,True
gmtOffSetMilliseconds,-14400000
underlyingSymbol,
quoteType,EQUITY
symbol,AMGN
underlyingExchangeSymbol,
headSymbol,
messageBoardId,finmb_24816
uuid,9376b97e-b428-3231-ba0b-142b20481cb4
market,us_market
annualHoldingsTurnover,
enterpriseToRevenue,5.885
beta3Year,
enterpriseToEbitda,12.014
52WeekChange,
morningStarRiskRating,
forwardEps,17.95
revenueQuarterlyGrowth,
sharesOutstanding,563265984
fundInceptionDate,
annualReportExpenseRatio,
totalAssets,
bookValue,14.543
sharesShort,19928916
sharesPercentSharesOut,0.0373
fundFamily,
lastFiscalYearEnd,1640908800
heldPercentInstitutions,0.82106
netIncomeToCommon,5722999808
trailingEps,9.701
lastDividendValue,
SandP52WeekChange,
priceToBook,17.552086
heldPercentInsiders,0.00228
nextFiscalYearEnd,1703980800
yield,
mostRecentQuarter,1648684800
shortRatio,6.83
sharesShortPreviousMonthDate,1648684800
floatShares,533115507
beta,0.590686
enterpriseValue,154880081920
priceHint,2
threeYearAverageReturn,
lastSplitDate,943228800
lastSplitFactor,2:1
legalType,
morningStarOverallRating,
earningsQuarterlyGrowth,-0.103
priceToSalesTrailing12Months,5.4635687
dateShortInterest,1651190400
pegRatio,1.98
ytdReturn,
forwardPE,14.220612
lastCapGain,
shortPercentOfFloat,0.0373
sharesShortPriorMonth,22522358
category,
fiveYearAverageReturn,
previousClose,244.77
regularMarketOpen,244.06
twoHundredDayAverage,225.4764
trailingAnnualDividendYield,0.02810802
payoutRatio,0.71269995
volume24Hr,
regularMarketDayHigh,247.63
navPrice,
averageDailyVolume10Day,2778960
regularMarketPreviousClose,244.77
fiftyDayAverage,244.6994
trailingAnnualDividendRate,6.88
open,244.06
averageVolume10days,2778960
expireDate,
algorithm,
dividendRate,7.76
exDividendDate,1652659200
circulatingSupply,
startDate,
regularMarketDayLow,243.005
currency,USD
trailingPE,26.31275
regularMarketVolume,2674323
lastMarket,
maxSupply,
openInterest,
marketCap,143779266560
volumeAllCurrencies,
strikePrice,
averageVolume,3108576
dayLow,243.005
ask,254.95
askSize,900
volume,2674323
fiftyTwoWeekHigh,258.45
fromCurrency,
fiveYearAvgDividendYield,2.77
fiftyTwoWeekLow,198.64
bid,254.5
tradeable,False
dividendYield,0.0319
bidSize,800
dayHigh,247.63
regularMarketPrice,255.26
preMarketPrice,
logo_url,https://logo.clearbit.com/amgen.com
